Cargando…
A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
Nanoparticle delivery systems have been shown to improve the therapeutic efficacy of anti-cancer drugs, including a variety of drugs for the treatment of hepatocellular carcinoma (HCC). However, the current systems show some limitations, and the delivery of more effective nanoparticle systems for an...
Autores principales: | Xie, Ming-Hua, Fu, Zai-Lin, Hua, Ai-Lian, Zhou, Ji-Fang, Chen, Qian, Li, Jian-Bo, Yao, Shen, Cai, Xin-Jun, Ge, Min, Zhou, Li, Wu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515951/ https://www.ncbi.nlm.nih.gov/pubmed/36185205 http://dx.doi.org/10.3389/fonc.2022.932156 |
Ejemplares similares
-
Core-shell nanocarriers with high paclitaxel loading for passive and active targeting
por: Jin, Zhu, et al.
Publicado: (2016) -
Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma
por: Gao, Benjian, et al.
Publicado: (2021) -
Electrospun self-emulsifying core-shell nanofibers for effective delivery of paclitaxel
por: Ge, Ruiliang, et al.
Publicado: (2023) -
Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma
por: Xiao, Susu, et al.
Publicado: (2022) -
Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate
por: Zhu, Jing, et al.
Publicado: (2018)